Determinants of risk factor control in subjects with coronary heart disease: A report from the EUROASPIRE III investigators

European Journal of Preventive Cardiology

Volumn 20, Issue 4, 2013, Pages 686-691

  Cooney, Marie Therese ^a   Kotseva, Kornelia ^b   Dudina, Alexandra ^a   Backer, Guy De ^c   Wood, David ^b   Graham, Ian ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Coronary heart disease; risk factors; secondary prevention

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS SURGERY; DEPRESSION; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GLYCEMIC CONTROL; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SMOKING; TREATMENT OUTCOME;

CORONARY HEART DISEASE; RISK FACTORS; SECONDARY PREVENTION;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; EDUCATIONAL STATUS; EUROPE; FEMALE; HEALTH STATUS; HUMANS; LOGISTIC MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; PATIENT COMPLIANCE; REFERRAL AND CONSULTATION; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; YOUNG ADULT;

EID: 84880269925     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312445562     Document Type: Article

References (7)

1. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 ; 14 (Suppl 2). S1 - S113
2. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009 ; 16: 121-137
3. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003 ; 10: S1 - S10
4. Albert NM, Birtcher KK, Cannon CP, et al. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database). Am J Cardiol. 2008 ; 101: 1242-1246
5. Saposnik G, Goodman SG, Leiter LA, et al. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?. Stroke. 2009 ; 40: 1417-1424
6. Kawecka-Jaszcz K, Jankowski P, Pajak A. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Int J Cardiol. 2003 ; 91: 15-23
7. Banta MR, Ma F, Bravata DM, et al. Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease. J Gen Intern Med. 2006 ; 21: 711-714